TenderlineUK
Procurement Intelligence
Search
Find a TenderAwarded without competition
Published 23 Mar 2022, 15:46 GMT

Official UK procurement notice

GRIDION™ MK1 OXFORD NANPORE CAPITAL AWARD

Official notice

Authority: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) (Central government)

GoodsAward procedure without prior publication of a call for competition
Sectors: Medical Devices & Pharma (33) Delivery: Wales (UKL22)
Awarded value£107,125published contract · exc. VAT
Awarded 17 Mar 2022no call for competition
Awarded to Oxford Nanopore Technologies

What is being bought

Published requirement description

NWSSP on behalf of Cardiff and Value UHB have been requested to purchase a GRIDION™ MK1 from Oxford Nanopore Technologies. Oxford Nanopore is listed as a supplier on Public Health England National Microbiology Framework Lot 1. The framework allows for direct award on technical justification. Further details within the main description of this notice

CPV: Medical equipments

The lotProcurement structure

single lot · no lot value published
Lot #1This notice is to confirm a contract has been awarded with Oxford Nanopore…Awarded

This notice is to confirm a contract has been awarded with Oxford Nanopore Technologies for the purchase of the GridION™ Mk1. The contract will be direct awarded on technical grounds via Public Health England National Microbiology Framework Lot 1. This notice is to be taken as the 10 day standstill period and will expire on the 11th March at midnight. If you have any questions regarding this notice please contact us through sell to wales.

Patents held by Oxford Nanopore Technologies in Europe and the United States, GridION Mk1 cannot be offered by other companies.

The equipment has the below unique features: -

  • 5 asynchronous sequencing ports allowing flexibility for sequencing runs.
  • Compatible with both MinION and Flongle flow cells, providing the option to go for a low or higher throughput sequencing run
  • A benchtop instrument with built in GPU capacity for real-time basecalling and analysis
  • Adaptive sampling capability, allowing for customisable computational target enrichment, with the same workflow
  • Nanopore sequencing has unrestricted read length, allowing for both short and long reads to be generated on the platform

Exclusivity for component used in Nanopore Detection Technology provided by Oxford Nanopore Technologies, as well as for methods performed by the same technology, is considered exclusive to the company and is protected by one or more of the following patents, owned or exclusively licensed to the company:

  • WO2010/086622 - US5795782A1
  • WO2012/164270 - US6015714A1
  • WO2013/014451 - US6362002B1
  • WO2014/013260 - EP1238275B1
  • WO2013/041878 - US8673556B2
  • WO2010/000789
Delivery: Wales
Extensions: Following a Prior Information Notice which expired on the 11th March 2022 with no challenges an award has now been made to oxford nanopore.

Procedure terms & legal framework

From the official record · publisher note attached
Procedure method
Award procedure without prior publication of a call for competition
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded without competition
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Direct award (no call for competition)
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
23 Mar 2022, 15:46 GMT
Last source update
23 Mar 2022, 15:46 GMT
Authority reference
CAV-DCO (21-22) 264
FTS notice number
2022/S 000-007898
Classification (CPV)
Medical equipments
Delivery area
Wales (UKL22)
Official registry OCID
ocds-h6vhtk-032574 Find a Tender
Why no open competition

The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons

Published justification

As per the description there are patents present on the equipment which has prevent competition from other suppliers.

Publisher note: (WA Ref:119819)

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 1
Awarded value £107,1251 contract exc. VAT
Bids received 1
Contracts signed 1latest 17 Mar 2022
Awarded toValueDateStatus
Oxford Nanopore Technologies£107,125 †—Awarded

Contracts

Bid statistics published by the authority

BidsSMEVCSEValid bid range
1bids · 1 electronic0——

Contracting authority & participating public bodies

NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

Contracting authorityCentral GovernmentBody governed by public lawHealth 4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw, Cardiff, UK, CF15 7QZContact email, phone

Dispute resolution & review bodies

  • High CourtReview body LondonContact phone

Bidders & participating suppliers

1 commercial party on the notice

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.